Decision sets ‘important precedent’ on federal powers over patented products, lawyer says
Thursday, February 04, 2021 @ 9:49 AM | By Luis Millán
Seven pharmaceutical companies, along with a string of intellectual property organizations and patients’ groups acting as interveners, which challenged the constitutionality of new regulations intended to lower patented drug prices were...
